Evidence map›Paper›PMID 41703601›Full record

ArticleAdvances in simulation (London, England)2026

Connecting data science and translational simulation.

Victoria Brazil

Abstract readLetter
In one paragraph

Article in Advances in simulation (London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Victoria BrazilTranslational Simulation Collaborative, Faculty of Health Sciences and Medicine, Bond University, Gold Coast, Australia. vbrazil@bond.edu.au.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Translational simulation is designed to explore and improve healthcare systems and performance. But this potential can only be realised if simulation activities generate actionable insights, using methods that are efficient and cost effective. Robust data strategies are required, embracing established quality‑improvement (QI) frameworks and the recent applications of artificial intelligence. Data collection, analysis and presentation are the primary functions of simulation for quality improvement. This requires translational simulation practitioners to adopt disciplined application of data science, if their diagnostic and interventional simulations are to be translated into tangible gains in healthcare quality and safety.This article is presented in three parts. First, I review contemporary data science principles in QI and emerging capabilities for data capture, synthesis, and tailored dissemination of findings. Second, I illustrate these principles through case vignettes drawn from the literature. Third, I synthesise these lessons to extend Nickson’s Input–Process–Output model, offering guidance for data strategy development for translational simulation initiatives. By integrating a rigorous data orientation into the foundational IPO schema, I argue that translational simulation can better realise its potential.

Indexed as

Data scienceHealthcare quality improvementTranslational simulation

Identifiers

PMID41703601
PMCPMC12910913

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.